scholarly journals Androgen Receptor CAG Repeat Length and TMPRSS2:ETS Prostate Cancer Risk: Results From the Prostate Cancer Prevention Trial

Urology ◽  
2014 ◽  
Vol 84 (1) ◽  
pp. 127-131 ◽  
Author(s):  
William D. Figg ◽  
Cindy H. Chau ◽  
Douglas K. Price ◽  
Cathee Till ◽  
Phyllis J. Goodman ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Androgen Receptor ◽  
Cancer Risk ◽  
Cancer Prevention ◽  
Prostate Cancer Risk ◽  
Repeat Length ◽  
Cag Repeat ◽  
Prevention Trial ◽  
Prostate Cancer Prevention ◽  
Prostate Cancer Prevention Trial

scholarly journals Serum androgens and prostate cancer risk: results from the placebo arm of the Prostate Cancer Prevention Trial

2015 ◽  
Vol 27 (2) ◽  
pp. 175-182 ◽  
Author(s):  
Jeannette M. Schenk ◽  
Cathee Till ◽  
Ann W. Hsing ◽  
Frank Z. Stanczyk ◽  
Zhihong Gong ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Cancer Risk ◽  
Cancer Prevention ◽  
Prostate Cancer Risk ◽  
Prevention Trial ◽  
Prostate Cancer Prevention ◽  
Prostate Cancer Prevention Trial ◽  
Serum Androgens

Assessing Prostate Cancer Risk: Results from the Prostate Cancer Prevention Trial

2006 ◽  
Vol 98 (8) ◽  
pp. 529-534 ◽  
Author(s):  
Ian M. Thompson ◽  
Donna Pauler Ankerst ◽  
Chen Chi ◽  
Phyllis J. Goodman ◽  
Catherine M. Tangen ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Cancer Risk ◽  
Cancer Prevention ◽  
Prostate Cancer Risk ◽  
Prevention Trial ◽  
Prostate Cancer Prevention ◽  
Prostate Cancer Prevention Trial
Sign in / Sign up

Export Citation Format

Share Document